Tag Archive | "Sorrento"

Sorrento Sells Cynviloq for $1.3B to NantPharma

Tags: ,

Sorrento Therapeutics agreed to sell its drug candidate Cynviloq (paclitaxel nanoparticle polymeric micelle) for up to $1.3 billion to NantPharma.

Read the full story

Licensing agreement for antibody and vaccine for obesity

Tags: , ,

Sorrento Therapeutics has entered into an antibody and vaccine development collaboration with The Scripps Research Institute. Read the full story